Congenital Heart Futures Reauthorization Act of 2017
Became Public Law No: 115-342.
Congressional Research Service
Official summary
Version 49 · Public Law · Dec 21, 2018
Congenital Heart Futures Reauthorization Act of 2017
(Sec. 2) This bill amends the Public Health Service Act to replace the authorization for a National Congenital Heart Disease Surveillance System with a requirement for the Department of Health and Human Services (HHS) to enhance and expand congenital heart disease research, surveillance, and awareness. (Congenital heart disease is a condition caused by a heart defect that is present at birth.)
HHS must award grants to nonprofit entities to conduct a study of congenital heart disease among all ages, including prevalence, health care utilization, and demographic factors. Collected information must be made available to the public.
(Sec. 3) HHS must report on research and other activities conducted regarding congenital heart disease.
Motion to reconsider laid on the table Agreed to without objection.
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436). (text: CR H10278)
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436).(text: CR H10278)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1222.
Mr. Walden moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H10278-10280, H10313-10314)
Message on Senate action sent to the House.
Passed Senate with an amendment by Unanimous Consent.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
The committee substitute withdrawn by Unanimous Consent. (CR S7525)
Measure laid before Senate by unanimous consent. (consideration: CR S7524-7525)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 555.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81). (text: CR H1238-1239)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81).(text: CR H1238-1239)
Considered as unfinished business. (consideration: CR H1246-1247)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 1222.
Considered under suspension of the rules. (consideration: CR H1238-1240)
Mr. Burgess moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 239.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-329.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-329.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Bill text & related measures
Text links open the official source. We currently store references to these documents.
Source last updated: Apr 21, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Explore the bill from different angles
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Neutral evidence review
Objective
Analyze H.R.1222 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
View full prompt & sources
Fairness and public impact
Progressive lens
Examine H.R.1222 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
View full prompt & sources
Institutions and government scope
Conservative lens
Examine H.R.1222 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
View full prompt & sources
Individual rights and government power
Liberty lens
Examine H.R.1222 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.